4Teen4 Pharmaceuticals
Latest round
- Series C
Last raised
- Oct 2025
Total raised
- $64M
Investors
- 4
About 4Teen4 Pharmaceuticals
Based in Hennigsdorf, Germany, and founded in 2013 by Dr.S. 4Teen4 Pharmaceuticals GmbH specializes in precision medicine for critical cardiac and vascular conditions. Their flagship product, Procizumab (PCZ), is a humanized monoclonal antibody designed to inhibit circulating Dipeptidyl Peptidase 3 (cDPP3), a key mediator in shock and circulatory failure. This product targets acute cardiovascular complications, particularly cardiogenic shock, seen in patients suffering from conditions such as acute myocardial infarction, acute decompensated heart failure, sepsis, and major surgeries. The company is in the clinical development phase, with a Phase 1b/2a trial scheduled to begin in Q1 2025 to establish dosing regimens for future studies. 4Teen4 Pharmaceuticals operates with a B2B model, focusing on partnerships with hospitals, healthcare providers, and research institutions. Revenue generation is expected through the commercialization of Procizumab, with pricing reflecting the critical nature of the therapy. The company anticipates long-term partnerships and bulk purchasing agreements for treating cardiogenic shock patients.
Who invested in 4Teen4 Pharmaceuticals
4 investors across 1 round
See all investors in 4Teen4 Pharmaceuticals
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series C
Oct 30, 2025
Amount
$64M
Investors
Questions about 4Teen4 Pharmaceuticals
Who invested in 4Teen4 Pharmaceuticals?
4Teen4 Pharmaceuticals has 4 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has 4Teen4 Pharmaceuticals raised?
4Teen4 Pharmaceuticals has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did 4Teen4 Pharmaceuticals last raise money?
4Teen4 Pharmaceuticals's most recent round on record is a Series C, in Oct 2025.
What does 4Teen4 Pharmaceuticals do?
Based in Hennigsdorf, Germany, and founded in 2013 by Dr.
Where is 4Teen4 Pharmaceuticals headquartered?
4Teen4 Pharmaceuticals is headquartered in Hennigsdorf, Germany.
Which VCs invest in companies like 4Teen4 Pharmaceuticals?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back pharmaceuticals companies at 4Teen4 Pharmaceuticals's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series C
Raising like 4Teen4 Pharmaceuticals? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.